| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,041,000 | 2,561,000 | 3,921,000 | 3,262,000 | | Cost of Revenue | 3,166,000 | 392,000 | 2,743,000 | 1,743,000 | | | Gross Profit | (125,000) | 2,169,000 | 1,178,000 | 1,519,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,273,000) | 1,329,000 | 44,000 | 664,000 | | Non Recurring | 73,000 |
-
|
-
|
-
| | Others | 224,000 | 203,000 | 207,000 | 195,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 924,000 | 637,000 | 927,000 | 660,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 74,000 | 57,000 | (44,000) | (140,000) | | Earnings Before Interest And Taxes | 954,000 | 684,000 | 893,000 | 529,000 | | Interest Expense | 129,000 | 133,000 | 145,000 | 146,000 | | Income Before Tax | 825,000 | 551,000 | 748,000 | 383,000 | | Income Tax Expense | 337,000 | 240,000 | 304,000 | 146,000 | | Minority Interest |
-
|
-
|
-
| (1,000) | | | | Net Income From Continuing Ops | 488,000 | 311,000 | 444,000 | 237,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (3,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 488,000 | 311,000 | 444,000 | 234,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $488,000 | $311,000 | $444,000 | $234,000 |
|
1.29% Nasdaq 
Income Statement
